Clinical Trials Directory

Trials / Completed

CompletedNCT01383642

Physiology of Vestibular Dysfunction and Clinical Implications

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
70 Years – 95 Years
Healthy volunteers
Accepted

Summary

Vestibular dysfunction is a known contributor to imbalance and fall risk, and may be a precursor to the frailty phenotype seen in the elderly population. A recent study found that vestibular dysfunction is common in the US population, and that the prevalence of this impairment increases steeply with age. However, it is unknown whether the aging process has global effects on the vestibular end-organ or whether specific structures, e.g. the semicircular canals or the otoliths, are selectively impaired. Moreover, the clinical implications of specific deficits of the vestibular end-organ are unclear. As such, the aims of this proposed research are: 1) to evaluate whether the normative aging process is predominantly associated with dysfunction of the semicircular canals (as measured by caloric and angular vestibulo-ocular reflex testing) or of the otoliths (as measured by vestibular-evoked myogenic potential (VEMP) testing); 2) to determine if there are any characteristic clinical features associated with the subtypes of vestibular dysfunction; and 3) to assess whether dysfunction of the semicircular canals or of the otoliths is associated with a higher risk of frailty and falls. The investigators plan to pursue these aims through a cross-sectional and prospective cohort study of a group of individuals age 70 and above. Vestibular physiologic tests will be administered to all study participants, and test results will be correlated with baseline clinical symptoms and frailty status as well as prospective one-year fall risk. A greater understanding of vestibular physiologic deficits and clinical implications in older individuals can inform the development of rational vestibular rehabilitation strategies that may more effectively mitigate the frailty phenotype and reduce fall risk.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention, observational study

Timeline

Start date
2010-07-01
Primary completion
2013-06-01
Completion
2018-06-01
First posted
2011-06-28
Last updated
2018-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01383642. Inclusion in this directory is not an endorsement.